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A 59-year-old postmenopausal woman, gravida 2, parity 2, was
admitted to our hospital, with the chief complaints with urinary
incontinence, frequent urination, lower back pain, and left lower-
limb edema. A transvaginal ultrasonographic examination showed
a multilocular cystic mass, with a heterogeneous solid part and
ﬂuid (Fig. 1A). Magnetic resonance imaging (MRI) showed amulticystic
pelvic mass, with a stained-glass pattern, measuring 14 cm in diameter.
T1-weighted gadolinium-enhanced MRI showed an enhanced solid
mass at the head of the tumor (Fig. 1B, C). Computed tomography did
not detect any signs of distant metastasis or lymphadenopathy. Serum
tumor markers including carcinoembryonic antigen (CEA), carbohy-was elevated to 1606 ng/ml.
Introduction
Alpha-fetoprotein (AFP) was ﬁrst described in the human fetus in
1956 (Bergstrand and Czar, 1956). AFP is synthesized by the developing
liver by at least 6 weeks of gestation. After birth, AFP rapidly disappears
and is not detected in the serum of healthy persons. This protein is a
useful tumor marker for detecting and monitoring malignant tumors,
such as germ cell tumors, especially yolk sac tumor (YST), and hepatoid
carcinoma, and is also signiﬁcant for conﬁrming the diagnosis. Epithelial
ovarian carcinoma rarely secretes AFP, especially in postmenopausal
women. We report here a 59-year-old postmenopausal woman with
AFP producing ovarian clear cell adenocarcinoma (CCA) with germ
cell tumor differentiation, simulating YST of fetal gut type. The serum
AFP level was elevated to 1606 ng/ml preoperatively, with a subsequent
decrease to the normal range after treatment. The tumor was com-
posed of conventional clear cells and those similar to the fetal gut.
Immunohistochemically, the cellular cytoplasm was diffusely positive
for AFP and GPC3, and focally positive for SALL4, which are known as
oncofetal proteins expressed in germ cell tumors.3-70 Kita-Oji, Akashi, Hyogo
c. This is an open access article underdrate antigen 19-9 (CA19-9), CA125, and squamous cell carcinoma
antigen (SCC) were within the normal range. Only serum AFP level
The patient underwent total abdominal hysterectomy with bilateral
salpingo-oophorectomy, omentectomy, appendectomy, pelvic lymph-
adenectomy, and para-aortic lymphadenectomy. The surgery was opti-
mal, that is, all gross tumors were resected almost completely. Ascitic
ﬂuid was cytologically negative. Histologically, the predominant
pattern in the tumor was characterized by the presence of cuboidal
or polygonal cells having a clear cytoplasm in solid nests and intermedi-
ate nuclear grade (Fig. 2A). No typical hobnail cells of conventional CCA
or Schiller Duval bodies commonly observed in YST were detected. We
also observed a fetal gut-like appearance of a clear cell pattern, showing
a tubular structure lined by clear columnar cells (Fig. 2B).
The immunohistochemical staining results are shown in Table 1. The
tumor cells were diffusely positive for AFP (Fig. 2C) and GPC3 (Fig. 2D)
and were focally positive for SALL4 (Fig. 2E). No apparent expression of
epithelial membrane antigen, cytokeratin 7, inhibin-α, calretinin, CD30,
human chorionic gonadotropin, phospholipase A2-activating protein,
C-kit, or hepatocyte nuclear factor-1beta (HNF-1β) was observed.
The combination of the morphological ﬁndings and immunohisto-
chemical expression proﬁles conﬁrmed the diagnosis of ovarian
CCA partially simulating YST of fetal gut type. The patient was staged
as pT2bN0M0.
Following an operation, thepatient underwent adjuvant chemother-
apy consisting of six cycles of paclitaxel and carboplatin. Serum AFP
level eventually decreased to the normal value after the surgery. AFP
level in the normal range has been maintained up to the present daythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1.Ultrasonography showing amultilocular, heterogeneous tumor (A). MRI showing a
multicystic pelvic mass with a stained-glass pattern: T1W1 image (B), T2W1 image (C).
Table 1
Immunohistochemical staining results:−, negative; 1+, b25%; 2+, 25–49%; 3+, 50%
or greater.
AE1/3 3+ CD30 −
EMA − HCG −
CK7 − PLAP −
LeuM1 1+ C-kit −
CEA 1+ Ki-67 labeling index 40%
Inhibin-α − SALL4 1+
Calretinin − GPC3 3+
AFP 3+ HNF-1β −
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23 months postoperatively.
Discussion
Most of the AFP-producing ovarian tumors occurring in young
women are germ cell tumors, speciﬁcally YSTs. However in elderly,
postmenopausal women, AFP-producing ovarian malignancies are
rarely encountered and their histology varies. Some AFP-producing
ovarian tumors in postmenopausal women have been documented,
such as endometrioid adenocarcinoma with a yolk sac component,
mucinous adenocarcinoma with a yolk sac component, CCA with a
serous adenocarcinoma component, and endometrioid adenocarcino-
ma with a clear cell component (Abe et al., 2008; Kamoi et al., 2002;
Esheba et al., 2008; Cetin et al., 2007; Maida et al., 1998). However,
the ovarian tumor in our case, which was largely composed of clearFig. 2.Microscopic examination. (A) Solid area composed of a sheet of polygonal or cuboidal cle
columnar cells having subnuclear or supranuclear vacuoles, characterized by fetal gut appearan
GPC3 in the cytoplasm. (E) Focal positive reaction for SALL4 in the nucleus.cells, was different from these other tumors histopathologically in
terms of lacking a YST component and forming glands similar to a
gland-like fetal gut. The clear cells were the predominant pattern in
histology and were not identiﬁed as a common ovarian CCA because
of a lack of hobnail cells and papillary architecture with eosinophilic
stromal core. The transcription factor hepatocyte nuclear factor-1β
(HNF1β), known to overexpress in CCA, was negative in this case.
The cellular cytoplasm was immunohistochemically positive for AFP.
These cells were also positive for SALL4 and GPC3, which are known
as oncofetal proteins expressed in germ cell tumors. Although AFP
producing hepatoid ovarian cancers were known to mimic clear cells,
the combination of morphological ﬁndings and immunohistochemical
expression proﬁle conﬁrmed the diagnosis of AFP-producing ovarian
CCA partially simulating YST of fetal gut type, not hepatoid ovarian
cancers.
The appropriate adjuvant therapy and biological behavior of this
type of tumor at recurrence need to be considered. This is because
this AFP-producing ovarian tumor appears to have two propensities:
an epithelial tumor and a germ cell tumor. Physicians need to be
aware that AFP-producing propensity may disappear in metastases,
even if the primary tumor is originally provided with AFP production
(Mostoﬁ, 1985). This kind of tumor might be a case with discrepancy
between function and morphology at recurrence because of latent
multipotentiality and heterogeneity.
In our case, in the therapeutic course, paclitaxel and carboplatin
were introduced as ﬁrst-line chemotherapy for six cycles. We selected
this treatment regimen because we focused on epithelial tumor, asar cells with intermediate nuclear grade. (H&E × 200) (B) Tubular structure lined by clear
ce. (C) Diffuse positive reaction for AFP in the cytoplasm. (D) Diffuse positive reaction for
26 A. Morimoto et al. / Gynecologic Oncology Reports 8 (2014) 24–26conventional CCA is the predominant pattern in this patient, in terms of
the prognosis rather than germ cell differentiation. Assuming that this
tumor relapses, wewould like to attempt to remove tissue and examine
its morphology in detail.
In our hospital, serum AFP level in ovarian tumors is not routinely
checked preoperatively, especially for elderly women. Yasuda and
Meguro reported a AFP-producing ovarian tumor in postmenopausal
women and reviewed the similar cases (Meguro and Yasuda, 2011).
According to them, most cases were a mixed-type tumor, including
epithelial malignancies or YST. The category of these rare tumors
remains controversial, and it is unknown which cases should be
investigated for the elevation of preoperative serum AFP level and
immunohistochemical expression for AFP. We suggest that serum
AFP levels should be measured in elderly or postmenopausal women
if their ovarian tumor shows multilocular or heterogeneous imaging
in an ultrasonographic examination.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gynor.2014.03.001.Conﬂict of interest statement
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